?SAFETY OVERSIGHT AND REPORTING GROUP The Safety Oversight and Reporting Group (SORG) will provide safety oversight for the consortia included in the Allergy and Asthma Disease Group (AADG), Autoimmune Disease Group (ADG), and Transplantation Group (TG). Rho currently provides safety monitoring and oversight for all of these consortia, except for Consortium of Food Allergy Research (CoFAR) and will maintain our high quality of safety reporting activities for these consortia and CoFAR as part of this cooperative agreement. The goal of the SORG is to achieve a high-quality, standardized process for receiving, processing, following, and reporting safety information for all clinical trials conducted by the consortia. Rho proposes to achieve this goal by creating a comprehensive safety management plan that will provide structure and detailed procedures for safety oversight activities across all studies. In addition, for each protocol, a protocol-specific safety management plan will be created to outline protocol-specific requirements. The safety management plan includes description of responsibilities, how adverse events (AEs) and serious adverse events (SAEs) will be monitored, real-time notifications to DAIT and other appropriate individuals of SAEs, safety reporting workflow and timeframes for when regulatory reports will be provided for submission to maintain compliance for U.S. and non-U.S regulations and requirements, protocol-specific templates, and identification of the reference safety document for determining regulatory expectedness/listedness. Additionally, the SORG will provide input during the development of study documents such as the protocol, investigator brochure, data forms, plans, and reports to ensure AEs and SAEs are monitored appropriately. For each protocol a lead product safety monitor (PSM) will be assigned. PSMs are assigned to a specific disease group, but everyone is cross-trained to provide back-up support. The PSM will educate site staff in how to appropriately recognize, record, and report AEs and SAEs. SAE data provided by the sites will be entered by the SORG into a secure, validated database specifically for entering, tracking, coding, reporting, analyzing and archiving SAE data. The SORG will also provide support to DAIT safety oversight structures by creating thorough, high-quality safety reports and presentations and by maintaining the DSMB Portal, a centralized place for all materials, agendas, and conflict of interest information.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Program Project or Center with Complex Structure Cooperative Agreement (UM2)
Project #
1UM2AI117870-01
Application #
8892718
Study Section
Special Emphasis Panel (ZAI1-PA-I (J2))
Project Start
2015-05-07
Project End
2022-04-30
Budget Start
2015-05-07
Budget End
2016-04-30
Support Year
1
Fiscal Year
2015
Total Cost
$472,271
Indirect Cost
$175,245
Name
Rho Federal Systems Division, Inc.
Department
Type
DUNS #
362726007
City
Chapel Hill
State
NC
Country
United States
Zip Code
27517
Calabrese, Sarah K; Earnshaw, Valerie A; Krakower, Douglas S et al. (2018) A Closer Look at Racism and Heterosexism in Medical Students' Clinical Decision-Making Related to HIV Pre-Exposure Prophylaxis (PrEP): Implications for PrEP Education. AIDS Behav 22:1122-1138
Gill, Michelle A; Liu, Andrew H; Calatroni, Agustin et al. (2018) Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab. J Allergy Clin Immunol 141:1735-1743.e9
Wildfire, Jeremy; Bailey, Ryan; Krouse, Rebecca Z et al. (2018) The Safety Explorer Suite: Interactive Safety Monitoring for Clinical Trials. Ther Innov Regul Sci 52:696-700
Simpson, Eric L; Villarreal, Miguel; Jepson, Brett et al. (2018) Patients with Atopic Dermatitis Colonized with Staphylococcus aureus Have a Distinct Phenotype and Endotype. J Invest Dermatol 138:2224-2233
Altman, Matthew C; Whalen, Elizabeth; Togias, Alkis et al. (2018) Allergen-induced activation of natural killer cells represents an early-life immune response in the development of allergic asthma. J Allergy Clin Immunol 142:1856-1866
Gergen, Peter J; Mitchell, Herman E; Calatroni, Agustin et al. (2018) Sensitization and Exposure to Pets: The Effect on Asthma Morbidity in the US Population. J Allergy Clin Immunol Pract 6:101-107.e2
du Toit, George; Sayre, Peter H; Roberts, Graham et al. (2018) Allergen specificity of early peanut consumption and effect on development of allergic disease in the Learning Early About Peanut Allergy study cohort. J Allergy Clin Immunol 141:1343-1353
Lawson, K; Bahnson, H T; Brittain, E et al. (2017) Letter of response to Greenhawt et al. 'LEAPing Through the Looking Glass: Secondary Analysis of the Effect of Skin Test Size and Age of Introduction on Peanut Tolerance after Early Peanut Introduction'. Allergy 72:1267-1271
Liu, Haiyun; Archer, Nathan K; Dillen, Carly A et al. (2017) Staphylococcus aureus Epicutaneous Exposure Drives Skin Inflammation via IL-36-Mediated T Cell Responses. Cell Host Microbe 22:653-666.e5
Calabrese, Sarah K; Krakower, Douglas S; Mayer, Kenneth H (2017) Integrating HIV Preexposure Prophylaxis (PrEP) Into Routine Preventive Health Care to Avoid Exacerbating Disparities. Am J Public Health 107:1883-1889

Showing the most recent 10 out of 33 publications